Outcomes and Determinant Factors of Percutaneous Transcatheter Occlusion among Children with Patent Ductus Arteriosus in the East Coast Malaysia: A 10 Year Experience
DOI:
https://doi.org/10.51407/mjpch.v28i2.228Keywords:
Patent ductus arteriosus, percutaneous transcatheter device closure, paediatrics, occluder, coilAbstract
Introduction: Transcatheter closure was a well-established procedure in patent ductus arteriosus (PDA). The aim of the study was to determine the outcomes, median time and PDAs closure from diagnosis and the predictive factors which influenced the decision for PDA closure. Material and methods: A 10-year retrospective record review was performed involving patients who had undergone transcatheter closure of PDA from January 2007 to January 2017 at a single centre in the North-eastern of Peninsular Malaysia. Descriptive statistics were used to examine all variables. Kaplan-Meier survival analysis was applied to determine median time for diagnosis and transcatheter closure of PDA. Multiple Cox regression analysis was used to identify predictors for early intervention of PDA closure. Results: A total of 123 patients were recruited with 65.9% of them were predominantly female. The age at the time of diagnosis was between 4-day to 14.5-year-old and median age for undergoing the procedure was 2.6-year-old (range:3-month to 15.8-year-old). The PDA size ranged between 0.2-12mm with 59% of the patients had large size PDA. Successful closure rate was achieved in 96.2 % with 3.8 % having very minimal residual shunt at 2 years post procedure. Complications were noted in 17 patients (4.0% major, 9.8% minor). Overall, the median time to diagnose and to close PDA were 6 months and 16.9 months respectively. Earlier intervention was likely to be performed in younger children (p<0.001) with weight of less than 10 kg (p<0.001). Conclusions: Transcatheter device closure was safe and effective in children with PDA with excellent outcome and minimal complication. Age and weight were the determinant factors for early PDA closure.
Downloads
References
Jin M, Liang YM, Wang XF, Guo BJ, Zheng K, Gu Y et al. A Retrospective Study of 1,526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus. Chin Med J (Engl). 2015;128(17):2284-9.
Djer MM, Saputro DD, Putra ST, Idris NS. Transcatheter closure of patent ductus arteriosus: 11 years of clinical experience in Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Pediatr Cardiol. 2015;36(5):1070-4.
Al-Hamash SM, Wahab HA, Khalid ZH, Nasser IV. Transcatheter closure of patent ductus arteriosus using ado device: retrospective study of 149 patients. Heart Views. 2012;13(1):1-6.
Baruteau AE, Hascoet S, Baruteau J, Boudjemline Y, Lambert V, Angel CY et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis. 2014;107(2):122-32.
Weisz DE, More K, McNamara PJ, Shah PS. PDA ligation and health outcomes: a meta-analysis. Pediatrics. 2014;133(4):e1024-46.
Krichenko A, Benson LN, Burrows P, Möes CA, MCLaughlin PFreeom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989;63(12):877-80.
Porstmann W, Wiemy L, Wamke H, Gerstberger G, Romanuik PA. The cathether closure of the patent ductus arteriosus: 62 cases treated without thoractomy. Radiol Clin North Am. 1971; 9: 203- 18.
Bergersen L, Giroud JM, Jacobs JP, Gerhe Franklin RC, Beland MJ, Krogmann ON, et al. Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2 - Nomenclature of complications associated with interventional cardiology). Cardiol Young. 2011;21(3):260-5.
Amoozgar H, Salehi S, Farhadi P, Edraki MR, Borzoee M, Ajami G, et al. Follow-Up Results of Device Occlusion of Patent Ductus Arteriosus. Iran J Pediatr. 2016;26(3):e3621
Choi GJ, Song J, Kim YS, Lee H, Huh J, Kang IS. Outcomes of transcatheter closure of ductus arteriosus in infants less than 6 months of age: a single-center experience. Korean J Pediatr. 2018;61(12):397-402.
El-Said HG, Bratincsak A, Foerster SR, Murohy JJ, Vincent J, Holzer R, et al. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc. 2013;2(6):e000424.
Backes CH, Rivera BK, Bridge JA, Armstrong AK, Boe BA, Berman DP, et al. Percutaneous Patent Ductus Arteriosus (PDA) Closure During Infancy: A Meta-analysis. Pediatrics. 2017;139(2):e20162927
Alwi M, Kang LM, Samion H, Latiff HA, Kandavel G, Zambahari R. Transcatheter occlusion of native persistent ductus arteriosus using conventional Gianturco coils. The American Journal of Cardiology. 1997; 79(10): 1430-32.
Bilkis AA, Alwi A, Hasri S, Latiff HA, Geetha K, Rehman MA, et al. The Amplatzer duct occluder: experience in 209 patients. Journal of the American College of Cardiology. 2001; 37 (1): 258-61
Bilkis AA, Alwi M, Hasri S, Haifa AL, Geetha K, Rehman MA, et al. The Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol. 2001;37(1):258-61.
Kang SL, Jivanji S, Mehta C, Tometzki A, Derrick G, Yates R, et al. Outcome after transcatheter occlusion of patent ductus arteriosus in infants less than 6 kg: A national study from United Kingdom and Ireland. Catheter Cardiovasc Interv. 2017;90(7):1135-44.
Chinawa JM, Chukwu BF, Chinawa AT, Duru CO. The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study. BMC Pulm Med. 2021;21(1):79
Masura J, Tittel P, Gavora P, Podnar T. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J. 2006;151(3):755 e7- e10.
Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037-99.
Đukić M, Parezanović V, Đorđević SA, Stefanović I, Miranović V, Ilić S, et al. Transcatheter closure of patent ductus arteriosus using Flipper coil and Amplatzer duct occluder: Ten-year experience from a single center. Serbian Archives of Medicine. 2017;145(11-12):564-70.
Amir Hamzah AR, Tiow CA, Koh GT, Sharifah AM. Transcatheter Closure of Patent Ductus Arteriosus: The Penang Hospital's Experience. Med J Malaysia. 2011;66(1):19-21.
Choi DY, Kim NY, Jung MJ, Kim SH. The results of transcatheter occlusion of patent ductus arteriosus: success rate and complications over 12 years in a single center. Korean Circ J. 2010;40(5):230-4.
Reese J, Laughon MM. The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment. J Pediatr. 2015;167(5):954-6.
Yang SW, Zhou YJ, Hu DY, Liu YY, Shi DM, Gui YH, et al. Feasibility and safety of transcatheter intervention for complex patent ductus arteriosus. Angiology. 2010;61(4):372-6
Kanabar K, Bootla D, Kaur N, Pruthvi CR, Krishnappa D, Santosh K, et al. Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥ 16 mm). Indian Heart J. 2020;72(2):107-12.
Backes CH, Kennedy KF, Locke M, Cua CM, Ball MK, Fick TA, et al. Transcatheter Occlusion of the Patent Ductus Arteriosus in 747 Infants <6 kg: Insights from the NCDR IMPACT Registry. JACC Cardiovasc Interv. 2017;10(17):1729-37
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Malaysian Journal of Paediatrics and Child Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
